{"nct_id":"NCT03470922","title":"A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2018-04-11","start_date_type":"ACTUAL","primary_completion_date":"2021-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2030-12-15","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["BMY"]}